---
schema_version: "secwatch.filing_event.v1"
accession: "0001000228-23-000024"
form_type: "8-K"
ticker: "HSIC"
cik: "0001000228"
company_name: "HENRY SCHEIN INC"
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T07:46:40.941857+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Henry Schein Q1 revenue down 3.8% to $3.1B; non-GAAP EPS $1.21 vs $1.44; lowers 2023 guidance to $5.18-$5.35

## Summary
- GAAP diluted EPS $0.91 vs $1.30; non-GAAP diluted EPS $1.21 vs $1.44.
- Net sales $3.1B, down 3.8% YoY; internal sales grew 6.3% ex-PPE and COVID test kits.
- Global Medical sales $1.0B down 17.2% (up 4.2% ex-PPE/COVID test kits); Dental $1.9B up 3.8%.
- 2023 non-GAAP EPS guidance cut to $5.18-$5.35 from prior $5.38; includes $0.05-$0.10 Biotech Dental dilution.
- Repurchased 1.2M shares for $100M in Q1; $415M remains authorized for buybacks.

## SEC filing metadata
- accession: 0001000228-23-000024
- form_type: 8-K
- ticker: HSIC
- cik: 0001000228
- company_name: HENRY SCHEIN INC
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000228/000100022823000024/0001000228-23-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000228/000100022823000024/hsic-20230509.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001000228-23-000024
- JSON: https://secwatch.observer/filing/0001000228-23-000024.json
- Plain text: https://secwatch.observer/filing/0001000228-23-000024.txt

## Key facts
- Earnings Releases
  HENRY SCHEIN INC reported the first quarter ended April 1, 2023 results: revenue $3.1 billion, net income $121 million, EPS $0.91.
  - Period: the first quarter ended April 1, 2023
  - Revenue: $3.1 billion
  - Net income: $121 million
  - EPS: $0.91
  - Result: reported results
  source text: 2 exhibit991.htm PRESS RELEASE MAY 9, 2023 exhibit991 -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS FIRST-QUARTER 2023 FINANCIAL RESULTS ● First-quarter 2023 net sales of $3.1 billion decreased 3.8% compared with first-quarter 2022; internal sales increased 6.3% in local currencies excluding sales of personal protective equipment (PPE) products and COVID-19
  evidence_url: https://www.sec.gov/Archives/edgar/data/1000228/000100022823000024/0001000228-23-000024-index.htm
- Earnings Releases
  HENRY SCHEIN INC reported full-year 2023 results: EPS $5.18 to $5.35. Guidance lowered.
  - Period: full-year 2023
  - EPS: $5.18 to $5.35
  - Guidance: lowered
  - Result: guidance update
  source text: Updating full-year 2023 non-GAAP diluted EPS guidance to $5.18 to $5.35, reflecting an estimated $0.05 to $0.10 first year dilution from the Biotech Dental acquisition
  evidence_url: https://www.sec.gov/Archives/edgar/data/1000228/000100022823000024/0001000228-23-000024-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.